2m 2m 2m 2m 2m 2m 2m
KARYOPHARM THER (KPTI)
NASDAQ
$9.85-$0.20 (-1.99%)
Price as of Jul 14, 2026 8:44 AM EDT- $227.8MMarket Cap
- 110.69%1-Year Change
- BiotechnologyIndustry
KARYOPHARM THER (KPTI)
$9.85-$0.20 (-1.99%)
KPTI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.05 | ||
Change | -$0.29 (-2.80%) | ||
Open | $10.19 | ||
High | $10.30 | ||
Low | $9.71 | ||
Previous Close | $10.34 | ||
Volume | 431,397 | ||
30-Day Average Volume | 546,563 | ||
1-Week Change | 4.47% | ||
1-Month Change | 5.79% | ||
1-Year Change | 110.69% | ||
3-Year Change | -59.15% | ||
5-Year Change | -92.83% | ||
Fundamentals | |||
Shares Outstanding | 22.7M | ||
Total Assets | $131.4M | ||
Market Cap | $227.8M | ||
Enterprise Value | $257.4M | ||
Period: QTR TTM FY | |||
Revenue | $29.2M | ||
Net Income | -$22.4M | ||
Free Cash Flow | -$22.7M | ||
EBIT | -$21.8M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $9.0M | ||
EPS | -$1.24 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 9 | ||
P/B | -1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/26/2025 | ||
Earnings & Revenue